We are live on ! Find out more
PMD

Psychemedics Corporation

Delisted

PMD was delisted on the 12th of December, 2024.

54 hedge funds and large institutions have $58M invested in Psychemedics Corporation in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

6% more funds holding

Funds holding: 5154 (+3)

1% less capital invested

Capital invested by funds: $58.4M → $58M (-$417K)

5% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 19

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
54
Holders Change
+3
Holders Change %
+5.88%
% of All Funds
1.23%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
5
Increased
18
Reduced
19
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
DA
51
Denali Advisors
California
$1K -$796 -40 -50%
IFAM
52
Institutional & Family Asset Management
Colorado
$1K
AIM
53
Alambic Investment Management
California
-$226K -11,751 Closed
Barclays
54
Barclays
United Kingdom
+$80 +4 New

PMD Hedge Fund Activity: Q3 2018 in Review

54 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q3 2018, worth a combined $58M — down 0.71% from $58.4M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new PMD positions and 1 closed out — a net gain of 4 holders — while 18 added to existing stakes and 19 trimmed.

The largest buyer was DePrince Race & Zollo Inc (DRZ), adding an estimated $4.56M. The largest seller was Moors & Cabot, cutting an estimated $6.38M.

  • 54 institutional investors held Psychemedics Corporation (PMD) as of Q3 2018, up from 51 in Q2 2018.
  • Funds reported $58M of Psychemedics Corporation stock for Q3 2018, down 0.71% quarter-over-quarter.
  • 5 funds opened new Psychemedics Corporation positions in Q3 2018 and 1 closed out, a net change of +4 holders.
  • The largest Psychemedics Corporation buyer in Q3 2018 was DePrince Race & Zollo Inc (DRZ), an estimated $4.56M added.
  • The largest Psychemedics Corporation seller in Q3 2018 was Moors & Cabot, an estimated $6.38M sold.

Based on aggregated 13F filings for Q3 2018.